يعرض 1 - 10 نتائج من 11 نتيجة بحث عن '"aldosterone antagonist/dt [Drug Therapy]"', وقت الاستعلام: 0.75s تنقيح النتائج
  1. 1
  2. 2
  3. 3
    مورد إلكتروني
  4. 4
    مورد إلكتروني
  5. 5
    مورد إلكتروني

    مصطلحات الفهرس: heartburn/co [Complication], human, hypertension/co [Complication], hypotension/co [Complication], kidney denervation, kidney denervation system, kidney function, kidney pain/co [Complication], low back pain/co [Complication], male, multicenter study, nausea/co [Complication], practice guideline, priority journal, prospective study, quality of life, resistant hypertension/dr [Drug Resistance], resistant hypertension/dt [Drug Therapy], resistant hypertension/th [Therapy], skin bruising/co [Complication], systolic blood pressure, vomiting/co [Complication], albumin/ec [Endogenous Compound], aldosterone antagonist/dt [Drug Therapy], alpha adrenergic receptor blocking agent/dt [Drug Therapy], angiotensin receptor antagonist/dt [Drug Therapy], beta adrenergic receptor blocking agent/dt [Drug Therapy], creatinine/ec [Endogenous Compound], cystatin C/ec [Endogenous Compound], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], kidney denervation system/am [Adverse Device Effect], kidney denervation system/ct [Clinical Trial], middle aged, adult, albumin blood level, antihypertensive therapy, application site bleeding/co [Complication], application site pain/co [Complication], article, backache/co [Complication], blood pressure, clinical article, computer assisted tomography, creatinine blood level, device safety, female, fever/co [Complication], flank pain/co [Complication], follow up, glomerulus filtration rate, headache/co [Complication], Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40875Test
    Click here for full text options
    LibKey Link

  6. 6
    مورد إلكتروني

    مصطلحات الفهرس: balloon catheter, artery thrombosis/co [Complication], article, blood pressure measurement, blood pressure monitoring, clinical effectiveness, controlled study, diastolic blood pressure, false aneurysm/co [Complication], female, flank pain/co [Complication], generator, glomerulus filtration rate, hematoma/co [Complication], human, infection/co [Complication], kidney artery stenosis/co [Complication], kidney artery stenosis/di [Diagnosis], kidney artery stenosis/su [Surgery], kidney denervation, kidney denervation system, major clinical study, male, multicenter study, prospective study, radiofrequency ablation, renal artery, resistant hypertension/dt [Drug Therapy], resistant hypertension/su [Surgery], safety, stent, systolic blood pressure, vomiting/co [Complication], adrenergic receptor blocking agent/dt [Drug Therapy], aldosterone antagonist/dt [Drug Therapy], alpha 1 adrenergic receptor blocking agent/dt [Drug Therapy], angiotensin receptor antagonist/dt [Drug Therapy], beta adrenergic receptor blocking agent/dt [Drug Therapy], calcium channel blocking agent/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/ae [Adverse Drug Reaction], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], diuretic agent/ae [Adverse Drug Reaction], diuretic agent/dt [Drug Therapy], hydroxymethylglutaryl coenzyme A reductase inhibitor/ae [Adverse Drug Reaction], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], nitrate/dt [Drug Therapy], renin inhibitor/dt [Drug Therapy], vasodilator agent/dt [Drug Therapy], estimated glomerular filtration rate, femoral artery thrombus/co [Complication], acute kidney failure/si [Side Effect], adult, angioplasty, antihypertensive therapy, artery injury, Article

    URL: EuroIntervention
    Click here for full text options
    LibKey Link

  7. 7
    مورد إلكتروني

    مصطلحات الفهرس: heartburn/co [Complication], human, hypertension/co [Complication], hypotension/co [Complication], kidney denervation, kidney denervation system, kidney function, kidney pain/co [Complication], low back pain/co [Complication], male, multicenter study, nausea/co [Complication], practice guideline, priority journal, prospective study, quality of life, resistant hypertension/dr [Drug Resistance], resistant hypertension/dt [Drug Therapy], resistant hypertension/th [Therapy], skin bruising/co [Complication], systolic blood pressure, vomiting/co [Complication], albumin/ec [Endogenous Compound], aldosterone antagonist/dt [Drug Therapy], alpha adrenergic receptor blocking agent/dt [Drug Therapy], angiotensin receptor antagonist/dt [Drug Therapy], beta adrenergic receptor blocking agent/dt [Drug Therapy], creatinine/ec [Endogenous Compound], cystatin C/ec [Endogenous Compound], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], kidney denervation system/am [Adverse Device Effect], kidney denervation system/ct [Clinical Trial], middle aged, adult, albumin blood level, antihypertensive therapy, application site bleeding/co [Complication], application site pain/co [Complication], article, backache/co [Complication], blood pressure, clinical article, computer assisted tomography, creatinine blood level, device safety, female, fever/co [Complication], flank pain/co [Complication], follow up, glomerulus filtration rate, headache/co [Complication], Article

  8. 8
    مورد إلكتروني

    مصطلحات الفهرس: balloon catheter, artery thrombosis/co [Complication], article, blood pressure measurement, blood pressure monitoring, clinical effectiveness, controlled study, diastolic blood pressure, false aneurysm/co [Complication], female, flank pain/co [Complication], generator, glomerulus filtration rate, hematoma/co [Complication], human, infection/co [Complication], kidney artery stenosis/co [Complication], kidney artery stenosis/di [Diagnosis], kidney artery stenosis/su [Surgery], kidney denervation, kidney denervation system, major clinical study, male, multicenter study, prospective study, radiofrequency ablation, renal artery, resistant hypertension/dt [Drug Therapy], resistant hypertension/su [Surgery], safety, stent, systolic blood pressure, vomiting/co [Complication], adrenergic receptor blocking agent/dt [Drug Therapy], aldosterone antagonist/dt [Drug Therapy], alpha 1 adrenergic receptor blocking agent/dt [Drug Therapy], angiotensin receptor antagonist/dt [Drug Therapy], beta adrenergic receptor blocking agent/dt [Drug Therapy], calcium channel blocking agent/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/ae [Adverse Drug Reaction], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], diuretic agent/ae [Adverse Drug Reaction], diuretic agent/dt [Drug Therapy], hydroxymethylglutaryl coenzyme A reductase inhibitor/ae [Adverse Drug Reaction], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], nitrate/dt [Drug Therapy], renin inhibitor/dt [Drug Therapy], vasodilator agent/dt [Drug Therapy], estimated glomerular filtration rate, femoral artery thrombus/co [Complication], acute kidney failure/si [Side Effect], adult, angioplasty, antihypertensive therapy, artery injury, Article

  9. 9
    مورد إلكتروني

    مصطلحات الفهرس: diabetic nephropathy/di [Diagnosis], diabetic nephropathy/dt [Drug Therapy], diabetic nephropathy/ep [Epidemiology], diabetic nephropathy/et [Etiology], diabetic nephropathy/su [Surgery], diabetic nephropathy/th [Therapy], diet therapy, disease surveillance, drug effect, drug targeting, glycemic control, human, inflammation, intracellular signaling, kidney biopsy, kidney blood flow, kidney metabolism, kidney pancreas transplantation, lifestyle modification, medical history, molecular pathology, nonhuman, oxidative stress, risk factor, risk reduction, screening test, tea, treatment planning, aldose reductase inhibitor/dt [Drug Therapy], aldosterone antagonist/cb [Drug Combination], aldosterone antagonist/dt [Drug Therapy], aliskiren/dt [Drug Therapy], aminoguanidine/dt [Drug Therapy], angiotensin receptor antagonist/cb [Drug Combination], angiotensin receptor antagonist/dt [Drug Therapy], atrasentan/dt [Drug Therapy], avosentan/dt [Drug Therapy], bardoxolone/dt [Drug Therapy], neutrophil gelatinase associated lipocalin/ec [Endogenous Compound], palosuran/dt [Drug Therapy], phosphodiesterase inhibitor/dt [Drug Therapy], pirfenidone/dt [Drug Therapy], pyridoxamine/dt [Drug Therapy], renin inhibitor/cb [Drug Combination], renin inhibitor/dt [Drug Therapy], sulodexide/dt [Drug Therapy], transforming growth factor beta1/ec [Endogenous Compound], unclassified drug, unindexed drug, vitamin D/dt [Drug Therapy], zinc, protein L FABP/ec [Endogenous Compound], vasculotropin/ec [Endogenous Compound], biological marker/ec [Endogenous Compound], calcium channel blocking agent/cb [Drug Combination], calcium channel blocking agent/dt [Drug Therapy], connective tissue growth factor/ec [Endogenous Compound], cystatin C/ec [Endogenous Compound], cytokine/ec [Endogenous Compound], dipeptidyl carboxypeptidase inhibitor/cb [Drug Combination], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], fish oil, hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], kidney injury molecule 1/ec [Endogenous Compound], alternative medicine, article, Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41642Test
    International Journal of Nephrology and Renovascular Disease
    Click here for full text options
    LibKey Link

  10. 10
    مورد إلكتروني

    مصطلحات الفهرس: diabetic nephropathy/di [Diagnosis], diabetic nephropathy/dt [Drug Therapy], diabetic nephropathy/ep [Epidemiology], diabetic nephropathy/et [Etiology], diabetic nephropathy/su [Surgery], diabetic nephropathy/th [Therapy], diet therapy, disease surveillance, drug effect, drug targeting, glycemic control, human, inflammation, intracellular signaling, kidney biopsy, kidney blood flow, kidney metabolism, kidney pancreas transplantation, lifestyle modification, medical history, molecular pathology, nonhuman, oxidative stress, risk factor, risk reduction, screening test, tea, treatment planning, aldose reductase inhibitor/dt [Drug Therapy], aldosterone antagonist/cb [Drug Combination], aldosterone antagonist/dt [Drug Therapy], aliskiren/dt [Drug Therapy], aminoguanidine/dt [Drug Therapy], angiotensin receptor antagonist/cb [Drug Combination], angiotensin receptor antagonist/dt [Drug Therapy], atrasentan/dt [Drug Therapy], avosentan/dt [Drug Therapy], bardoxolone/dt [Drug Therapy], neutrophil gelatinase associated lipocalin/ec [Endogenous Compound], palosuran/dt [Drug Therapy], phosphodiesterase inhibitor/dt [Drug Therapy], pirfenidone/dt [Drug Therapy], pyridoxamine/dt [Drug Therapy], renin inhibitor/cb [Drug Combination], renin inhibitor/dt [Drug Therapy], sulodexide/dt [Drug Therapy], transforming growth factor beta1/ec [Endogenous Compound], unclassified drug, unindexed drug, vitamin D/dt [Drug Therapy], zinc, protein L FABP/ec [Endogenous Compound], vasculotropin/ec [Endogenous Compound], biological marker/ec [Endogenous Compound], calcium channel blocking agent/cb [Drug Combination], calcium channel blocking agent/dt [Drug Therapy], connective tissue growth factor/ec [Endogenous Compound], cystatin C/ec [Endogenous Compound], cytokine/ec [Endogenous Compound], dipeptidyl carboxypeptidase inhibitor/cb [Drug Combination], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], fish oil, hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], kidney injury molecule 1/ec [Endogenous Compound], alternative medicine, article, Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41642Test
    International Journal of Nephrology and Renovascular Disease
    Click here for full text options
    LibKey Link